Cargando…
Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders
The aim of this study was to evaluate quantitative aberrations of novel fetal-specific epigenetic markers in maternal plasma of pregnancies with hypertensive disorders. We compared the concentrations of DSCR3, RASSF1A, and SRY as cell-free fetal DNA markers in 188 normal pregnancies, 16 pregnancies...
Autores principales: | Kim, Hyun Jin, Kim, Shin Young, Lim, Ji Hyae, Kwak, Dong Wook, Park, So Yeon, Ryu, Hyun Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691144/ https://www.ncbi.nlm.nih.gov/pubmed/26694356 http://dx.doi.org/10.3390/ijms161226201 |
Ejemplares similares
-
Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013) -
Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011) -
Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction
por: Kwak, Dong Wook, et al.
Publicado: (2020) -
Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21
por: Lim, Ji Hyae, et al.
Publicado: (2014) -
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013)